These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20367192)

  • 1. Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders.
    Inoue K; Takano H
    Expert Opin Investig Drugs; 2010 Apr; 19(4):513-20. PubMed ID: 20367192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of urinary trypsin inhibitor on systemic inflammatory response induced by lipopolysaccharide.
    Inoue K; Takano H; Yanagisawa R; Yoshikawa T
    J Clin Biochem Nutr; 2008 Nov; 43(3):139-42. PubMed ID: 19015747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide.
    Inoue K; Takano H; Shimada A; Yanagisawa R; Sakurai M; Yoshino S; Sato H; Yoshikawa T
    Mol Pharmacol; 2005 Mar; 67(3):673-80. PubMed ID: 15576631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of urinary trypsin inhibitor in lung expression of proinflammatory cytokines accompanied by lethal liver injury in mice.
    Inoue K; Takano H; Sato H; Yanagisawa R; Yoshikawa T
    Immunopharmacol Immunotoxicol; 2009; 31(3):446-50. PubMed ID: 19259882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide.
    Inoue K; Takano H; Yanagisawa R; Sakurai M; Shimada A; Yoshino S; Sato H; Yoshikawa T
    Exp Biol Med (Maywood); 2005 Apr; 230(4):281-7. PubMed ID: 15792950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary trypsin inhibitor reduces inflammatory response in kidney induced by lipopolysaccharide.
    Ueki M; Taie S; Chujo K; Asaga T; Iwanaga Y; Ono J; Maekawa N
    J Biosci Bioeng; 2007 Oct; 104(4):315-20. PubMed ID: 18023806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidative role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide.
    Inoue K; Takano H; Yanagisawa R; Sakurai M; Shimada A; Sato H; Kato Y; Yoshikawa T
    Int J Mol Med; 2005 Dec; 16(6):1029-33. PubMed ID: 16273282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation.
    Slofstra SH; Groot AP; Obdeijn MH; Reitsma PH; ten Cate H; Spek CA
    Am J Respir Crit Care Med; 2007 Sep; 176(6):602-9. PubMed ID: 17600275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice heterozygous for adrenomedullin exhibit a more extreme inflammatory response to endotoxin-induced septic shock.
    Dackor R; Caron K
    Peptides; 2007 Nov; 28(11):2164-70. PubMed ID: 17889965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lipopolysaccharide-induced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo.
    Molor-Erdene P; Okajima K; Isobe H; Uchiba M; Harada N; Shimozawa N; Okabe H
    Thromb Haemost; 2005 Jul; 94(1):136-45. PubMed ID: 16113797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
    Chatterjee S; Premachandran S; Shukla J; Poduval TB
    J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism.
    Fallarino F; Pallotta MT; Matino D; Gargaro M; Orabona C; Vacca C; Mondanelli G; Allegrucci M; Boon L; Romani R; Talesa VN; Puccetti P; Grohmann U
    Immunobiology; 2015 Feb; 220(2):315-21. PubMed ID: 25278421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
    Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
    Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A glutamine synthetase inhibitor increases survival and decreases cytokine response in a mouse model of acute liver failure.
    Jambekar AA; Palma E; Nicolosi L; Rasola A; Petronilli V; Chiara F; Bernardi P; Needleman R; Brusilow WS
    Liver Int; 2011 Sep; 31(8):1209-21. PubMed ID: 21745296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired fertility in female mice lacking urinary trypsin inhibitor.
    Sato H; Kajikawa S; Kuroda S; Horisawa Y; Nakamura N; Kaga N; Kakinuma C; Kato K; Morishita H; Niwa H; Miyazaki J
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1154-60. PubMed ID: 11243855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation.
    Wu YJ; Ling Q; Zhou XH; Wang Y; Xie HY; Yu JR; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):53-8. PubMed ID: 19208516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of urinary trypsin inhibitor in experimental shock.
    Ohnishi H; Suzuki K; Niho T; Ito C; Yamaguchi K
    Jpn J Pharmacol; 1985 Oct; 39(2):137-44. PubMed ID: 2418241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary trypsin inhibitor treatment ameliorates acute lung and liver injury resulting from sepsis in a rat model.
    Zhou LW; Wang YL; Yan XT; He XH
    Saudi Med J; 2008 Mar; 29(3):368-73. PubMed ID: 18327361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
    Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.